Evolv (EVLV) Director Michael Ellenbogen Sells Shares After Exercise

What Happened
Michael Ellenbogen, a director of Evolv Technologies (EVLV), exercised options and immediately sold the resulting 80,752 shares on August 17, 2026. He exercised options at $0.24 per share (exercise cost $19,380) and sold the shares at a weighted-average price of $5.59 for gross proceeds of about $451,404 (approx. $432,024 net of the exercise cost, before taxes/fees). The sales were executed under a Rule 10b5-1 trading plan.

Key Details

• Transaction date: 2026-08-17; Form 4 filed: 2026-08-19 (filed promptly).
• Exercise: 80,752 shares acquired at $0.24 each (total $19,380). (Code M)
• Sale: 80,752 shares sold at a weighted-average price of $5.59 (total ~$451,404). (Code S)
• Derivative conversion: Form shows the derivative converted/disposed in connection with the exercise (Code M, $0.00).
• Shares owned after transaction: not specified in this filing.
• Footnotes: sales were made pursuant to a Rule 10b5-1 plan entered June 12, 2025 (F1); the sale price is a weighted average across multiple transactions (F2); the option vesting schedule noted (F3).
• If you want exact per-trade sale prices, the filer offers to provide the breakdown on request (per F2).

Context
This was an exercise-then-sell (cashless-style) transaction: the insider exercised vested options and sold the resulting shares the same day. Sales under 10b5-1 plans are pre-arranged and often reflect a planned disposition rather than a spontaneous view on the company. This filing is informational and does not on its own indicate the insider’s future outlook.